New Insights from Courier Health's 2026 Patient-Centricity Report in Biopharma

The 2026 State of Patient-Centricity in Biopharma: Key Findings

Courier Health has unveiled its 2026 edition of The State of Patient-Centricity in Biopharma, a pivotal report that delves into the complexities of managing patient experiences within the specialty pharmaceutical sector. As the biopharma landscape continues to evolve, the insights provided by this report are more crucial than ever.

Comprehensive Survey Results

Drawing on the perspectives of over 170 industry professionals from 87 biopharma companies, including a significant number of senior-level individuals from rare disease sectors, the report is touted as the most thorough to date. The central conclusions are both alarming and indicative of a pressing need for reform in operational practices and data management.

One of the most striking findings is the claim that nearly 60% of biopharma organizations lack coherent data systems, leading to fragmentation that hampers everyday operations and affects patient experiences adversely. This failure to integrate data is not just an operational inconvenience; it is rather a fundamental issue preventing timely interventions and contributing to inconsistent patient interactions. Moreover, only a mere 9% of respondents indicated their teams had achieved sufficient data maturity to leverage AI effectively. This juxtaposition of enthusiasm for AI with the stark reality of data deficiencies depicts a significant disconnect within the industry.

The AI Gap in Biopharma

The report highlights crucial disparities in AI readiness across different segments of the biopharma industry. It reveals that larger and mid-sized firms are much more inclined to invest in automation and AI technologies to enhance operational efficiency and patient-centric methodologies. Despite this, only 12% of companies reported having formal approval processes and governance structures for implementing AI tools, leaving many to adopt these innovations in a rather informal manner. Moreover, smaller biotechs appear to prioritize patient and provider education over AI investment, with just 11% identifying AI as a priority in their financial planning.

Danny Sigurdson, Founder and CEO of Courier Health, emphasizes the critical nature of addressing these gaps. He warns, "You can't build the future of patient engagement on a broken foundation. The companies investing in the data fundamentals and the right AI partners today are the ones that will define what patient-centricity looks like for years to come."

Changes in Commercial Models

The findings of the 2026 report further illuminate a marked shift towards internal management of Patient Services teams. The share of companies employing internal or hybrid teams for these services surged from 60% to 75% over the past year, indicating a significant transformation in how businesses are structuring their commercial operations. Teams focused on Field Access and Reimbursement also observed an increase in internal team membership, reinforcing the trend.

Methodology and Insights

The data for this report were collected via an online survey conducted between January 13 and February 3, 2026. With 25 questions covering program performance and AI adoption, the respondents comprised professionals engaged specifically in commercial roles within biopharma manufacturers. This detailed approach supports a nuanced understanding of the operational challenges currently facing the industry.

Conclusion

As the biopharma industry stands at a crossroads, Courier Health's insights underscore the necessity for better data infrastructure and AI integration. The findings not only chart the current landscape but also project the importance of adapting to technological advancements to improve patient-centric care.

For those keen to explore more detailed insights, the full report is available for download, featuring interviews with executives from major companies, including AstraZeneca, Genentech, and Pfizer. In a rapidly changing industry, being well-informed is essential for those invested in advancing healthcare outcomes.

For further information on Courier Health and its initiatives, please visit www.courierhealth.com or follow their updates on LinkedIn.